Herbalife Ltd (HLF)
(Delayed Data from NYSE)
$8.81 USD
-0.07 (-0.79%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.80 -0.01 (-0.11%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Herbalife Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 5,062 | 5,204 | 5,803 | 5,542 | 4,877 |
Cost Of Goods | 1,191 | 1,174 | 1,239 | 1,151 | 958 |
Gross Profit | 3,871 | 4,031 | 4,564 | 4,391 | 3,919 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,515 | 3,486 | 3,829 | 3,751 | 3,351 |
Income After Depreciation & Amortization | 356 | 545 | 734 | 641 | 568 |
Non-Operating Income | 13 | 19 | -20 | 9 | 36 |
Interest Expense | 166 | 139 | 153 | 133 | 153 |
Pretax Income | 203 | 425 | 561 | 516 | 451 |
Income Taxes | 61 | 104 | 114 | 144 | 140 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 142 | 321 | 447 | 373 | 311 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 142 | 321 | 447 | 373 | 311 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 470 | 661 | 842 | 741 | 666 |
Depreciation & Amortization (Cash Flow) | 113 | 115 | 108 | 100 | 98 |
Income After Depreciation & Amortization | 356 | 545 | 734 | 641 | 568 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 100.20 | 98.50 | 108.30 | 134.50 | 141.60 |
Diluted EPS Before Non-Recurring Items | 2.21 | 3.40 | 4.79 | 3.71 | 2.82 |
Diluted Net EPS (GAAP) | 1.42 | 3.23 | 4.13 | 2.77 | 2.20 |
Fiscal Year end for Herbalife Ltd falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,215.00 | 1,281.30 | 1,314.00 | 1,252.10 |
Cost Of Goods | NA | 287.60 | 303.20 | 301.60 | 298.60 |
Gross Profit | NA | 927.40 | 978.10 | 1,012.40 | 953.50 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 871.60 | 871.40 | 889.00 | 883.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 55.80 | 106.70 | 123.40 | 70.50 |
Non-Operating Income | NA | 11.50 | 1.00 | 0.00 | 0.00 |
Interest Expense | NA | 49.60 | 38.50 | 38.40 | 39.40 |
Pretax Income | NA | 17.70 | 69.20 | 85.00 | 31.10 |
Income Taxes | NA | 7.50 | 26.40 | 25.10 | 1.80 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 10.20 | 42.80 | 59.90 | 29.30 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 10.20 | 42.80 | 59.90 | 29.30 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 100.70 | 100.40 | 99.50 | 100.20 |
Diluted EPS Before Non-Recurring Items | NA | 0.28 | 0.65 | 0.74 | 0.54 |
Diluted Net EPS (GAAP) | NA | 0.10 | 0.43 | 0.60 | 0.29 |